Dr. Tomas Hode
CEO and co-founder at Immunophotonics Inc
SPIE Involvement:
Conference Program Committee | Author
Profile Summary

Dr. Hode, CEO and co-founder of Immunophotonics Inc, has been engaged in the medical laser device industry since 1994, and the biotech industry since 2007. In parallel with his engagement in the industry he received a PhD in astrobiology in 2005 at Stockholm University, after which he took a position as a Research Associate at Portland State University. In 2007 Dr. Hode returned to industry but kept his ties to academia through a courtesy position as an Associate Research Professor at Portland State University, and more recently as a Visiting Scientist at SP Technical Research Institute of Sweden, Section of Medical Devices at the Chemistry and Materials Technology Department.
Publications (21)

PROCEEDINGS ARTICLE | March 7, 2017
Proc. SPIE. 10065, Biophotonics and Immune Responses XII
KEYWORDS: Oncology, Laser therapeutics, Biomedical optics, Cancer, Breast cancer, Tumors, Skin, Laser energy, Melanoma, Solids

PROCEEDINGS ARTICLE | April 27, 2016
Proc. SPIE. 9709, Biophotonics and Immune Responses XI
KEYWORDS: Phototherapy, Oncology, Biomedical optics, Cancer, Breast cancer, Clinical research, Current controlled current source, Clinical trials

PROCEEDINGS ARTICLE | March 9, 2015
Proc. SPIE. 9324, Biophotonics and Immune Responses X
KEYWORDS: Biomedical optics, Cancer, Breast cancer, Tumors, Skin, Melanoma, Laser irradiation, Single walled carbon nanotubes, Carbon nanotubes, Clinical trials

PROCEEDINGS ARTICLE | March 13, 2014
Proc. SPIE. 8944, Biophotonics and Immune Responses IX
KEYWORDS: Breast, Oncology, Laser therapeutics, Cancer, Breast cancer, Tumors, Chromium, Semiconductor lasers, Laser irradiation, Clinical trials

PROCEEDINGS ARTICLE | February 27, 2014
Proc. SPIE. 8944, Biophotonics and Immune Responses IX
KEYWORDS: Nanotechnology, Near infrared, Tumors, Tissues, Molecules, Flow cytometry, Absorbance, Single walled carbon nanotubes, Absorption, Carbon nanotubes

PROCEEDINGS ARTICLE | February 27, 2014
Proc. SPIE. 8944, Biophotonics and Immune Responses IX
KEYWORDS: Optical fibers, Oncology, Biomedical optics, Cancer, Breast cancer, Tumors, Fiber lasers, Melanoma, Laser irradiation, Clinical trials

Showing 5 of 21 publications
Conference Committee Involvement (18)
Mechanisms of Photobiomodulation Therapy XIV
2 February 2019 | San Francisco, California, United States
Biophotonics and Immune Responses XIII
29 January 2018 | San Francisco, California, United States
Mechanisms of Photobiomodulation Therapy XIII
27 January 2018 | San Francisco, California, United States
Biophotonics and Immune Responses XII
30 January 2017 | San Francisco, California, United States
Mechanisms of Photobiomodulation Therapy XII
28 January 2017 | San Francisco, California, United States
Showing 5 of 18 published special sections
SIGN IN TO:
  • View contact details

UPDATE YOUR PROFILE
Is this your profile? Update it now.
Don’t have a profile and want one?

Back to Top